Not as dead as a dodo?

Episode Summary

Executive Summary: Tech Life explores the promise and ethics of de-extinction through Colossal Biosciences’ efforts to revive mammoths, dodos, and thylacines, contrasting the company’s pro-innovation case with ethical criticism that it creates novel hybrids and diverts attention from conservation. The episode then pivots to the practical science of alcohol-free beer, explaining how reverse osmosis preserves flavor while removing alcohol.

Main Topics: De-extinction as a biotech ambition (Priority: 5/5): Colossal Biosciences says it aims to bring back the woolly mammoth, Tasmanian tiger and dodo using synthetic biology, gene editing and developmental biology. Ethical objections to 'bringing back' extinct species (Priority: 5/5): Critics argue the term de-extinction is misleading, because the result is not an exact resurrected species but a genetically engineered organism, raising welfare and consent concerns. Conservation and commercialization (Priority: 4/5): Colossal frames its work as complementary to conservation and claims the technologies can spin out into other businesses such as drug discovery and plastic degradation. Technical hurdles in reviving extinct animals (Priority: 4/5): The discussion covers incomplete genomes, surrogate mothers, gestation challenges, and artificial wombs as potential solutions for mammoth and thylacine projects. Alcohol-free beer technology (Priority: 4/5): A second segment explains how breweries use reverse osmosis to remove alcohol while retaining flavor, making alcohol-free beer more appealing to consumers. Market demand for sober products (Priority: 3/5): Bars and breweries report growing demand for alcohol-free options, especially around Dry January and among consumers seeking realistic-tasting alternatives.

Key Arguments: Colossal argues de-extinction is both a species-restoration effort and a technology-development platform, with conservation and human-health spinouts as part of the business model. The company says conservation alone is too slow to counter human-driven biodiversity loss, so new biotechnologies are needed to prevent further extinctions. Critics contend that de-extinction is a euphemism: the result is not an extinct species revived, but a novel engineered animal built from fragments of DNA and a close relative. Ethicists warn that using sentient animals such as elephants as surrogates creates major welfare problems and should not proceed without public consultation. Opponents say de-extinction risks creating a false sense that extinction can be technologically reversed, distracting from habitat protection, conflict mitigation, and traditional conservation. The alcohol-free beer segment shows how breweries use reverse osmosis to keep flavor profiles intact, making de-alcoholized beer more commercially viable than brewing without alcohol from the start. Suppliers note the process requires high sanitation standards and can yield pure alcohol byproducts that can be reused in other beverages.

Data Points: Funding raised by Colossal Biosciences: Over $400 million - Used to support de-extinction and related biotech development First mammoth calves target: Late 2028 - Colossal’s stated timeline for its first mammoth calves Tasmanian tiger timeline: 6 to 7 years - CEO’s estimate for seeing a thylacine after accelerating development Thylacine genome completeness: 99.9% complete with 45 gaps - Colossal says it has assembled a near-complete genome for the Tasmanian tiger Foundation donation: $1.5 billion - Announced donation to George Church’s lab for artificial wombs for endangered species Wild mammal biomass remaining: About 4% - Cited by Melanie Challenger to argue that wild nature is already severely diminished Domestic/control mammal biomass: 70% - She says most mammal biomass is in farms or otherwise under human control Yangtze River dolphin extinction declaration: 2006 - The episode opens with a recording of the dolphin, described as likely never to be heard again

Pivotal Quotes: "That is not what we are doing. What we are doing is genetically engineering an entire Novel organism that has some of the characteristics and some of the genetic material of a mammoth, but this is a genetically engineered organism." — Melanie Challenger: Explaining why she says 'de-extinction' is misleading "We think that people should put money in conservation. We think everyone should write checks to conservation. But the reality is that while conservation works, it's not working at the speed at which we are eradicating species." — Ben Lamb: Defending Colossal’s view that new technologies are needed alongside conservation "You can't bring an animal back from the dead." — Melanie Challenger: Her core objection to the premise of de-extinction

Implications: The episode suggests de-extinction may accelerate useful biotech, but it also raises serious animal-welfare, ecological, and honesty concerns. For listeners, it frames a wider question: should humanity try to remake lost species, or focus resources on protecting the ones that remain?